BlaumCBrunnerFJKrögerF, et al.Modifiable lifestyle risk factors and CRP in patients with coronary artery disease – implications for an anti-inflammatory treatment target population. Eur J Prev Cardiol. Epub ahead of print 2019. DOI: 10.1177/2047487319885458.
ArnettDKBlumenthalRSAlbertMA, et al.2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2019; 74: 1376–1414.
4.
StampferMJHuFBMansonJE, et al.Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med2000; 343: 16–22.
5.
ChiuveSERexrodeKMSpiegelmanD, et al.Primary prevention of stroke by healthy lifestyle. Circulation2008; 118: 947–954.
6.
YusufSHawkenSOunpuuS, et al.Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet2004; 364: 937–952.
7.
LvJYuCGuoY, et al.Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population. J Am Coll Cardiol2017; 69: 1116–1125.
8.
ChristodoulidisGVittorioTJFudimM, et al.Inflammation in coronary artery disease. Cardiol Rev2014; 22: 279–288.
9.
WilsonPW. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Am J Med2008; 121(10 Suppl. 1): S15–S20.
10.
MoreiraDMda SilvaRLVieiraJL, et al.Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Am J Cardiovasc Drugs2015; 15: 1–11.
11.
RossR. Atherosclerosis – an inflammatory disease. N Engl J Med1999; 340: 115–126.
12.
DaneshJWheelerJGHirschfieldGM, et al.C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med2004; 350: 1387–1397.
13.
LiXJiYKangJ, et al.Association between blood neutrophil-to-lymphocyte ratio and severity of coronary artery disease: evidence from 17 observational studies involving 7017 cases. Medicine (Baltimore)2018; 97: e12432–e12432.
14.
BielasHMeister-LangrafRESchmidJP, et al.Acute stress disorder and C-reactive protein in patients with acute myocardial infarction. Eur J Prev Cardiol2018; 25: 298–305.
15.
MunkhaugenJOtterstadJEDammenT, et al.The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event. Eur J Prev Cardiol2018; 25: 923–931.
16.
YousufOMohantyBDMartinSS, et al.High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?J Am Coll Cardiol2013; 62: 397–408.
17.
MareeAOFitzgeraldDJ. Aspirin and coronary artery disease. Thromb Haemost2004; 92: 1175–1181.
18.
RidkerPMDanielsonEFonsecaFA, et al.Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med2008; 359: 2195–2207.
19.
BohulaEAGiuglianoRPCannonCP, et al.Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. Circulation2015; 132: 1224–1233.
20.
RaberIMcCarthyCPVaduganathanM, et al.The rise and fall of aspirin in the primary prevention of cardiovascular disease. Lancet2019; 393: 2155–2167.
21.
RidkerPMEverettBMThurenT, et al.Anti-inflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med2017; 377: 1119–1131.
22.
HuangAVitaJAVenemaRC, et al.Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem2000; 275: 17399–17406.
23.
ChomistekAKChiuveSEEliassenAH, et al.Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J Am Coll Cardiol2015; 65: 43–51.
24.
LakoskiSGCushmanMCriquiM, et al.Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J2006; 152: 593–598.
25.
KheraAMcGuireDKMurphySA, et al.Race and gender differences in C-reactive protein levels. J Am Coll Cardiol2005; 46: 464–469.
26.
Lopez-CandalesAHernández BurgosPMHernandez-SuarezDF, et al.Linking chronic inflammation with cardiovascular disease: from normal aging to the metabolic syndrome. J Nat Sci2017; 3: e341–e362.
27.
FeinFScheuerJRifkinHPortD. Heart disease in diabetes mellitus: Theory and practice, New York: Elsevier, 1990.
28.
HuxleyRBarziFWoodwardM. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ2006; 332: 73–78.
29.
CarusoGFrestaCGFidilioA, et al.Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages. Antioxidants (Basel)2019; 8: 281–299.
